Geneos Wealth Management Inc.
Position in GALT — Galectin Therapeutics Inc
CIK 1764754
ENGLEWOOD, CO
Position in GALT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,115,581
+$443,395 QoQ
Shares Held
240,427
-0.2% QoQ
Ownership
0.238%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#15
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $3,299,056 across 37 Biotechnology names. GALT ranks #1 (33.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GALT |
Galectin Therapeutics Inc
This page
|
240,427 | $1,115,581 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
12,199 | $954,815 | |
| 3 | TWST |
Twist Bioscience Corp
|
5,300 | $545,264 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
|
48,100 | $124,579 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
1,269 | $69,718 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
5,754 | $50,376 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $50,169 |
All Filings in GALT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,115,581 | 240,427 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $672,186 | 240,927 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,012,240 | 243,327 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,527,142 | 360,175 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $893,025 | 423,235 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $521,470 | 427,435 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $501,726 | 388,935 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $970,571 | 352,935 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $889,818 | 393,725 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $977,151 | 408,850 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $684,999 | 412,650 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $801,312 | 417,350 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $607,176 | 421,650 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $897,540 | 427,400 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $491,324 | 434,800 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $725,676 | 445,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $626,267 | 478,067 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $764,374 | 474,767 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $995,187 | 480,767 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,906,503 | 491,367 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,575,254 | 492,267 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $1,110,185 | 511,606 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $1,087,757 | 485,606 | Shares | Sole | 2021-05-19 | |
| 2020-09-30 | $98,835 | 37,017 | Shares | Sole | 2021-09-07 | |
| 2020-06-30 | $113,272 | 37,017 | Shares | Sole | 2021-09-07 | |
| 2020-03-31 | $81,830 | 41,750 | Shares | Sole | 2021-09-07 | |
| No filing history on record for this holder in this stock. | ||||||